nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials
|
Magee, D.E. |
|
|
31 |
1 |
p. 50-60 |
artikel |
2 |
Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?
|
Loprinzi, C.L. |
|
|
31 |
1 |
p. 5-6 |
artikel |
3 |
Cognitive behavioral therapy or graded exercise therapy compared with usual care for severe fatigue in patients with advanced cancer during treatment: a randomized controlled trial
|
Poort, H. |
|
|
31 |
1 |
p. 115-122 |
artikel |
4 |
Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer
|
Nipp, R.D. |
|
|
31 |
1 |
p. 123-130 |
artikel |
5 |
Editorial Board
|
|
|
|
31 |
1 |
p. iii |
artikel |
6 |
Electronic symptom monitoring: not everyone fits the mold
|
Loh, K.P. |
|
|
31 |
1 |
p. 13-14 |
artikel |
7 |
Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma
|
Ugurel, S. |
|
|
31 |
1 |
p. 144-152 |
artikel |
8 |
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges
|
Heil, J. |
|
|
31 |
1 |
p. 61-71 |
artikel |
9 |
Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life
|
Hazell, S.Z. |
|
|
31 |
1 |
p. 96-102 |
artikel |
10 |
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives
|
Martinelli, E. |
|
|
31 |
1 |
p. 30-40 |
artikel |
11 |
Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions
|
Haenssle, H.A. |
|
|
31 |
1 |
p. 137-143 |
artikel |
12 |
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ✰
|
Zucca, E. |
|
|
31 |
1 |
p. 17-29 |
artikel |
13 |
Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer
|
Genkinger, J.M. |
|
|
31 |
1 |
p. 103-114 |
artikel |
14 |
Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy ✰
|
Beijers, A.J.M. |
|
|
31 |
1 |
p. 131-136 |
artikel |
15 |
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
|
Yoshino, T. |
|
|
31 |
1 |
p. 88-95 |
artikel |
16 |
Obesity, height, and advanced prostate cancer: extending current evidence toward precision prevention
|
Dickerman, B.A. |
|
|
31 |
1 |
p. 7-8 |
artikel |
17 |
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF v600 mutation–positive melanoma receiving adjuvant vemurafenib
|
Ascierto, P.A. |
|
|
31 |
1 |
p. 153-159 |
artikel |
18 |
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)
|
Kundranda, M. |
|
|
31 |
1 |
p. 79-87 |
artikel |
19 |
Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer ✰
|
De Ruysscher, D. |
|
|
31 |
1 |
p. 41-49 |
artikel |
20 |
Relation of cetuximab-induced skin toxicity and early tumor shrinkage in metastatic colorectal cancer patients: results of the randomized phase 3 trial FIRE-3 (AIO KRK0306)
|
Holch, J.W. |
|
|
31 |
1 |
p. 72-78 |
artikel |
21 |
Should we optimize cytotoxic therapy by dosing to neutropenia? Lessons from TAS-102
|
Kasi, P.M. |
|
|
31 |
1 |
p. 15-16 |
artikel |
22 |
Table of Contents
|
|
|
|
31 |
1 |
p. i-ii |
artikel |
23 |
Thanks to Referees 2019
|
|
|
|
31 |
1 |
p. 1-4 |
artikel |
24 |
The challenge of identifying which stage III melanoma patients need adjuvant treatment and with what
|
Nathan, P. |
|
|
31 |
1 |
p. 11-12 |
artikel |
25 |
Transferring effective interventions for cancer-related fatigue from the adjuvant to the advanced cancer session: does it work?
|
May, A.M. |
|
|
31 |
1 |
p. 9-10 |
artikel |